Centerbridge Partners, L.P. Bausch Health Companies Inc. Transaction History
Centerbridge Partners, L.P.
- $498 Million
- Q1 2024
A detailed history of Centerbridge Partners, L.P. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Centerbridge Partners, L.P. holds 2,303,500 shares of BHC stock, worth $16.7 Million. This represents 4.91% of its overall portfolio holdings.
Number of Shares
2,303,500Holding current value
$16.7 Million% of portfolio
4.91%Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
282Shares Held
278MCall Options Held
21.5MPut Options Held
21.8M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$251 Million3.29% of portfolio
-
Goldentree Asset Management LP New York, NY27.6MShares$200 Million23.66% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$191 Million20.29% of portfolio
-
Franklin Resources Inc San Mateo, CA15.9MShares$115 Million0.06% of portfolio
-
National Bank Of Canada15.7MShares$113 Million0.29% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.62B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...